SLC19A2 and rheumatoid arthritis: Specifically, CRYBG1, RRM2, and MMP1 showed higher levels in the RA group than in the normal group, whereas SLC19A2 showed significantly lower expression (Figure 8D), consistent with observation in the training cohort.